PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
22.98%
Net income growth under 50% of BB's 590.91%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-4.60%
Negative yoy D&A while BB is 6.17%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-62.95%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
133.73%
SBC growth of 133.73% while BB is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
98.38%
Well above BB's 77.57% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
779.62%
AR growth of 779.62% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.15%
Lower 'other working capital' growth vs. BB's 76.21%. David Dodd would see fewer unexpected short-term demands on cash.
-110.50%
Negative yoy while BB is 1165.59%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
23.77%
Operating cash flow growth below 50% of BB's 132.28%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
44.83%
CapEx growth well above BB's 7.97%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-6.33%
Both yoy lines negative, with BB at -810713.29%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-134.84%
Negative yoy purchasing while BB stands at 78.07%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
129.99%
We have some liquidation growth while BB is negative at -9.19%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-70.34%
Both yoy lines negative, with BB at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
72.80%
We have mild expansions while BB is negative at -149.47%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment growth of 100.00% while BB is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
120.17%
Stock issuance far above BB's 32.55%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-92.99%
We cut yoy buybacks while BB is 100.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.